Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma
NCT04049344
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Renal Cell Carcinoma
Interventions
DRUG:
Decitabine; Oxaliplatin
Sponsor
Zhejiang Cancer Hospital